AKT1 and neoplasm: PI3K-AKT-mTOR pathway have aberrant activation in more than 29% of patients with multiple types of malignancies and regulate key tumor processes including angiogenesis, cell proliferation, metabolism, migration and apoptosis (Hoxhaj and Manning, 2020; Yang et al., 2019).